Phensuximide: Difference between revisions

	WikiDoc Resources for Phensuximide
Articles
Most recent articles on Phensuximide Most cited articles on Phensuximide Review articles on Phensuximide Articles on Phensuximide in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Phensuximide Images of Phensuximide Photos of Phensuximide Podcasts & MP3s on Phensuximide Videos on Phensuximide
Evidence Based Medicine
Cochrane Collaboration on Phensuximide Bandolier on Phensuximide TRIP on Phensuximide
Clinical Trials
Ongoing Trials on Phensuximide at Clinical Trials.gov Trial results on Phensuximide Clinical Trials on Phensuximide at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Phensuximide NICE Guidance on Phensuximide NHS PRODIGY Guidance FDA on Phensuximide CDC on Phensuximide
Books
Books on Phensuximide
News
Phensuximide in the news Be alerted to news on Phensuximide News trends on Phensuximide
Commentary
Blogs on Phensuximide
Definitions
Definitions of Phensuximide
Patient Resources / Community
Patient resources on Phensuximide Discussion groups on Phensuximide Patient Handouts on Phensuximide Directions to Hospitals Treating Phensuximide Risk calculators and risk factors for Phensuximide
Healthcare Provider Resources
Symptoms of Phensuximide Causes & Risk Factors for Phensuximide Diagnostic studies for Phensuximide Treatment of Phensuximide
Continuing Medical Education (CME)
CME Programs on Phensuximide
International
Phensuximide en Espanol Phensuximide en Francais
Business
Phensuximide in the Marketplace Patents on Phensuximide
Experimental / Informatics
List of terms related to Phensuximide

Phensuximide
Clinical data
MedlinePlus	a682237
ATC code	N03AD02 (WHO) ;
Pharmacokinetic data
Protein binding	21%
Identifiers
	IUPAC name 1-methyl-3-phenyl-pyrrolidine-2,5-dione;
CAS Number	86-34-0 ;
PubChem CID	6839;
DrugBank	DB00832 ;
ChemSpider	6578 ;
UNII	6WVL9C355G;
KEGG	D00508 ;
ChEMBL	ChEMBL797 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C11H11NO2
Molar mass	189.211 g/mol
3D model (JSmol)	Interactive image;
	SMILES O=C2N(C(=O)CC2c1ccccc1)C;
	InChI InChI=1S/C11H11NO2/c1-12-10(13)7-9(11(12)14)8-5-3-2-4-6-8/h2-6,9H,7H2,1H3 ; Key:WLWFNJKHKGIJNW-UHFFFAOYSA-N ;
(verify)

VisualWikitext

Latest revision as of 15:21, 13 April 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Phensuximide is an anticonvulsant in the succinimide class.

External links

Template:DiseasesDB
Rankin G, Cressey-Veneziano K, Wang R, Brown P (1986). "Urinary tract effects of phensuximide in the Sprague-Dawley and Fischer 344 rat". J Appl Toxicol. 6 (5): 349–56. doi:10.1002/jat.2550060509. PMID 3772011.

This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it.

Template:Anticonvulsants

@@ Line 1: / Line 1: @@
-{{drugbox
+{{Drugbox
+| verifiedrevid = 464200749
 | IUPAC_name = 1-methyl-3-phenyl-pyrrolidine-2,5-dione
-| image = Phensuximide.svg
+| image = Phensuximide.png
+<!--Clinical data-->
+| tradename =
+| MedlinePlus = a682237
+| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
+| pregnancy_US = <!-- A / B / C / D / X -->
+| pregnancy_category =
+| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
+| legal_UK = <!-- GSL / P / POM / CD -->
+| legal_US = <!-- OTC / Rx-only -->
+| legal_status =
+| routes_of_administration =
+<!--Pharmacokinetic data-->
+| bioavailability =
+| protein_bound = 21%
+| metabolism =
+| elimination_half-life =
+| excretion =
+<!--Identifiers-->
+| CASNo_Ref = {{cascite|correct|CAS}}
+| CAS_number_Ref = {{cascite|correct|??}}
 | CAS_number = 86-34-0
 | ATC_prefix = N03
 | ATC_suffix = AD02
 | ATC_supplemental =
 | PubChem = 6839
-| DrugBank = APRD00496
+| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
-| C = 11 | H = 11 | N = 1 | O = 2
+ | DrugBank = DB00832
+| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
+| ChemSpiderID = 6578
+| UNII_Ref = {{fdacite|correct|FDA}}
+| UNII = 6WVL9C355G
+| KEGG_Ref = {{keggcite|correct|kegg}}
+| KEGG = D00508
+| ChEMBL_Ref = {{ebicite|correct|EBI}}
+| ChEMBL = 797
+<!--Chemical data-->
+| C=11 | H=11 | N=1 | O=2
 | molecular_weight = 189.211 g/mol
-| bioavailability =
+| smiles = O=C2N(C(=O)CC2c1ccccc1)C
-| protein_bound = 21%
+| InChI = 1/C11H11NO2/c1-12-10(13)7-9(11(12)14)8-5-3-2-4-6-8/h2-6,9H,7H2,1H3
-| metabolism =
+| InChIKey = WLWFNJKHKGIJNW-UHFFFAOYAW
-| elimination_half-life =
+| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
-| excretion =
+| StdInChI = 1S/C11H11NO2/c1-12-10(13)7-9(11(12)14)8-5-3-2-4-6-8/h2-6,9H,7H2,1H3
-| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
+| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
-| pregnancy_US = <!-- A / B / C / D / X -->
+| StdInChIKey = WLWFNJKHKGIJNW-UHFFFAOYSA-N
-| pregnancy_category =
-| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
-| legal_UK = <!-- GSL / P / POM / CD -->
-| legal_US = <!-- OTC / Rx-only -->
-| legal_status =
-| routes_of_administration =
 }}
+              __NOTOC__
+{{SI}}
+{{CMG}}
+==Overview==
 '''Phensuximide''' is an [[anticonvulsant]] in the [[succinimide]] class.
 ==External links==
 * {{DiseasesDB|31648}}
-* {{cite journal | author = Rankin G, Cressey-Veneziano K, Wang R, Brown P | title = Urinary tract effects of phensuximide in the Sprague-Dawley and Fischer 344 rat. | journal = J Appl Toxicol | volume = 6 | issue = 5 | pages = 349-56 | year = 1986 | id = PMID 3772011}}
+* {{cite journal | author = Rankin G, Cressey-Veneziano K, Wang R, Brown P | title = Urinary tract effects of phensuximide in the Sprague-Dawley and Fischer 344 rat. | journal = J Appl Toxicol | volume = 6 | issue = 5 | pages = 349–56 | year = 1986 | pmid = 3772011 | doi = 10.1002/jat.2550060509}}
 {{anticonvulsant-stub}}
 {{Anticonvulsants}}
+[[Category:Drug]]

Phensuximide: Difference between revisions

Latest revision as of 15:21, 13 April 2015

Overview

External links

Navigation menu

Search